Use of interferon beta for the treatment of alopecia areata
Номер патента: EP2744509A1
Опубликовано: 25-06-2014
Автор(ы): Hans-Günther GRIGOLEIT, Ivan G. Ivanov
Принадлежит: TIGO GMBH
Опубликовано: 25-06-2014
Автор(ы): Hans-Günther GRIGOLEIT, Ivan G. Ivanov
Принадлежит: TIGO GMBH
Реферат: The present invention relates to a medicament for the treatment of alopecia areata. Interferon beta of the present invention may be administered to the subject suffering from said disorder topically (e.g. intradermally) or systemically. The present invention further encompasses compositions comprising interferon beta for use as a medicament in the treatment of alopecia areata. Said compositions may comprise other active agents, such as statins. In a preferred embodiment, interferon beta-lb is administered intradermally once a week for 4 to 6 weeks at a dose level of 4.5 to 30 microgram per 10 cm 2 treated area.
Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin
Номер патента: US20160324832A1. Автор: Cathrin Scherner,Tobias Mann,Ludger Kolbe,Ursula WENNSORRA. Владелец: Beiersdorf AG. Дата публикации: 2016-11-10.